Viewing StudyNCT00063999



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00063999
Status: COMPLETED
Last Update Posted: 2021-10-19
First Post: 2003-07-08

Brief Title: Doxorubicin Hydrochloride Cisplatin and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Sponsor: GOG Foundation
Organization: GOG Foundation

Organization Data

Organization: GOG Foundation
Class: NETWORK
Study ID: GOG-0209
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: GOG Foundation
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH